Literature DB >> 17993959

Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC)-201 versus 7.5% hypertonic HBOC-201.

Fernando A Rivera-Chavez1, Sergio Huerta, Ronnie Brown, Gregory B York, Joseph P Minei.   

Abstract

BACKGROUND: Hemoglobin-based oxygen carrier (HBOC) resuscitation has been associated with increased systemic and pulmonary vascular resistances (SVR, PVR), which may result in reduced blood flow and severe pulmonary hypertension. The physiologic and immunologic properties of 7.5% hypertonic saline solution (HTS), such as reduction of SVR and PVR, as well as inhibition of neutrophil and endothelial activation may be beneficial in reducing some of these undesirable effects of HBOCs. The aim of this study was to evaluate the hemodynamic effects of the HBOC and HBOC-201 suspended in 7.5% hypertonic saline solution (HT-HBOC) when compared with standard HBOC resuscitation.
METHODS: Thirty-two domestic crossbred pigs (50-60 kg) were hemorrhaged to a mean arterial pressure (MAP) of 35 mm Hg +/- 5 mm Hg for 45 minutes and resuscitated to a baseline mean arterial pressure using the following groups: (1) sham, no hemorrhage; (2) shed blood + lactated Ringer's solution; (3) standard HBOC-201; (4) hypertonic saline 7.5%; (5) hypertonic 7.5% HBOC-201. After resuscitation, observation was continued for 4 hours. Hemodynamic variables, oxygen consumption, and arterial blood gases were monitored continuously. Data were analyzed using analysis of variance.
RESULTS: SVR (p = 0.001), PVR (p = 0.001), and MPAP (p = 0.01) were significantly reduced in the HT-HBOC group compared with the standard HBOC group.
CONCLUSION: In this model of hemorrhagic shock, hypertonic HBOC-201- resuscitated pigs had significantly reduced SVR and PVR, as well as mean pulmonary artery pressure (MPAP) and increased cardiac output. HT-HBOC may be beneficial in reducing the undesirable effects of standard HBOC-201. The mechanisms of these beneficial effects need to be investigated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993959     DOI: 10.1097/TA.0b013e3181561157

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model.

Authors:  Bjorn Kyungsuck Song; William H Nugent; Paula F Moon-Massat; Roland N Pittman
Journal:  Microvasc Res       Date:  2014-07-18       Impact factor: 3.514

2.  Glutaraldehyde-polymerized bovine hemoglobin and phosphodiesterase-5 inhibition.

Authors:  Robert W Gotshall; Karyn L Hamilton; Benjamin Foreman; Martha C Tissot van Patot; David C Irwin
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

3.  Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats.

Authors:  David Irwin; Paul W Buehler; Abdu I Alayash; Yiping Jia; Joe Bonventura; Ben Foreman; Molly White; Robert Jacobs; Brian Piteo; Martha C TissotvanPatot; Karyn L Hamilton; Robert W Gotshall
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-24       Impact factor: 6.914

4.  Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide.

Authors:  Binglan Yu; Gian Paolo Volpato; Keqin Chang; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2009-01       Impact factor: 7.892

Review 5.  New Applications of HBOC-201: A 25-Year Review of the Literature.

Authors:  Min Cao; Yong Zhao; Hongli He; Ruiming Yue; Lingai Pan; Huan Hu; Yingjie Ren; Qin Qin; Xueliang Yi; Tao Yin; Lina Ma; Dingding Zhang; Xiaobo Huang
Journal:  Front Med (Lausanne)       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.